![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » TaqMan miRNA Assays Enable Molecule Detection in Brain Cancer
TaqMan miRNA Assays Enable Molecule Detection in Brain Cancer
May 9, 2005
In conjunction with the European Society of Human Genetics (ESHG) Annual Meeting, Applied Biosystems Group, an Applera business, and Dartmouth Medical School presented data using a preliminary version of Applied Biosystems TaqMan MicroRNA (miRNA) Assays to profile microRNA expression in human brain cancer samples.
Yahoo News (http://biz.yahoo.com/bw/050509/95349.html?.v=1)
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
21Oct